Evidence map›Paper›PMID 29961805›Full record

ArticleNucleic acids research2018

Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription.

Ivan A Belashov, David W Crawford, Chapin E Cavender, Peng Dai, Patrick C Beardslee, David H Mathews, Bradley L Pentelute, Brian R McNaughton, Joseph E Wedekind

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Full-Length NADBiochemistry · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. RNA-Binding Macrocyclic Peptides.Frontiers in molecular biosciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ivan A BelashovDepartment of Biochemistry & Biophysics, Center for RNA Biology, and Center for AIDS Research, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA.
David W CrawfordDepartment of Chemistry, Colorado State University, Fort Collins, CO 80523, USA.
Chapin E CavenderDepartment of Biochemistry & Biophysics, Center for RNA Biology, and Center for AIDS Research, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA.
Peng DaiDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Patrick C BeardsleeDepartment of Chemistry, Colorado State University, Fort Collins, CO 80523, USA.
David H MathewsDepartment of Biochemistry & Biophysics, Center for RNA Biology, and Center for AIDS Research, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA.
Bradley L PenteluteDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Brian R McNaughtonDepartment of Chemistry, Colorado State University, Fort Collins, CO 80523, USA.
Joseph E WedekindDepartment of Biochemistry & Biophysics, Center for RNA Biology, and Center for AIDS Research, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA.
University of Rochester · USColorado State University · USBroad Institute · USMassachusetts Institute of Technology · US

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI SCOTT, EMILY E · 1985 to 2011
$38.9M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
Mechanisms of Action On Non-Coding RNA MoleculesR01GM063162 · NIGMS · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2001 to 2024
$6.8M
Supporting RNAstructure: Software for RNA AnalysisR01GM076485 · NIGMS · UNIVERSITY OF ROCHESTER · PI MATHEWS, DAVID H. · 2006 to 2021
$4.7M
Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Training in HIV Replication and PathogenesisT32AI049815 · NIAID · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2001 to 2020
$3.5M
Identification of Protein Drug Leads That Address Challenges to Small Molecule CeR01GM107520 · NIGMS · COLORADO STATE UNIVERSITY · PI KENNAN, ALAN J · 2014 to 2018
$1.4M
NIH Training Grant in the Chemistry-Biology InterfaceT32GM118283 · NIGMS · UNIVERSITY OF ROCHESTER · PI BREN, KARA L., FASAN, RUDI · 2017 to 2021
$850k
Cyclic Peptide Inhibitors of HIV-1 ProliferationR01GM123864 · NIGMS · UNIVERSITY OF ROCHESTER · PI KENNAN, ALAN J, WEDEKIND, JOSEPH E · 2017 to 2018
$797k
Cyclic Peptide Inhibitors of HIV-1 ProliferationR01AI150463 · NIAID · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2019 to 2020
$774k
A shared macromolecular X-ray diffraction system in RochesterS10RR026501 · NCRR · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2010 to 2010
$478k
NCRR NIH HHS P41 RR001209NCRR NIH HHS S10 RR026501NIAID NIH HHS P30 AI078498NIAID NIH HHS R01 AI150463NIAID NIH HHS T32 AI049815NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM063162NIGMS NIH HHS R01 GM076485NIGMS NIH HHS R01 GM107520NIGMS NIH HHS R01 GM123864NIGMS NIH HHS T32 GM068411NIGMS NIH HHS T32 GM118283
6 · The paper itself

Abstract

Natural and lab-evolved proteins often recognize their RNA partners with exquisite affinity. Structural analysis of such complexes can offer valuable insight into sequence-selective recognition that can be exploited to alter biological function. Here, we describe the structure of a lab-evolved RNA recognition motif (RRM) bound to the HIV-1 trans-activation response (TAR) RNA element at 1.80 Å-resolution. The complex reveals a trio of arginines in an evolved β2-β3 loop penetrating deeply into the major groove to read conserved guanines while simultaneously forming cation-π and salt-bridge contacts. The observation that the evolved RRM engages TAR within a double-stranded stem is atypical compared to most RRMs. Mutagenesis, thermodynamic analysis and molecular dynamics validate the atypical binding mode and quantify molecular contributions that support the exceptionally tight binding of the TAR-protein complex (KD,App of 2.5 ± 0.1 nM). These findings led to the hypothesis that the β2-β3 loop can function as a standalone TAR-recognition module. Indeed, short constrained peptides comprising the β2-β3 loop still bind TAR (KD,App of 1.8 ± 0.5 μM) and significantly weaken TAR-dependent transcription. Our results provide a detailed understanding of TAR molecular recognition and reveal that a lab-evolved protein can be reduced to a minimal RNA-binding peptide.

Indexed as

HIV Long Terminal RepeatRNA Recognition MotifAmino Acid SequenceCrystallography, X-RayDNA, RecombinantEnzyme-Linked Immunosorbent AssayEscherichia coliGenes, SyntheticHIV-1Models, MolecularMolecular Dynamics SimulationNucleic Acid ConformationOligopeptidesPoint MutationProtein BindingProtein ConformationDNA, RecombinantOligopeptidesRNA, Double-Stranded

Identifiers

PMID29961805
PMCPMC6061845
OpenAlexW2810018398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.